Marsh & McLennan Companies faces a split valuation picture heading into its next earnings report. An Excess Returns model estimates intrinsic value at about $281 per share, implying a 36.5% discount to the current price, while a P/E analysis suggests the stock is overvalued at 22.0 times earnings compared to a tailored fair P/E of 13.6 times. The company has returned 35.1% over five years, and upcoming Q2 2026 results are expected to show single-digit earnings growth. Broader valuation checks score 3 out of 6, indicating a mixed outlook rather than a clear bargain or overvaluation.
Marsh & McLennan Companies, Inc.Mixed valuation signals from Excess Returns model (undervalued) and P/E analysis (overvalued) ahead of Q2 earnings.